Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The early follow-up of 131I-treatment of thyrotoxicosis

  • 24 Accesses

  • 3 Citations


No general agreement exists concerning the optimal time for the first control of patients treated with 131I for thyrotoxicosis. Ten consecutive cases were followed clinically, and current laboratory thyroid tests were frequently performed during a 14 week period to point out the optimal control time and the best setup of control parameters for such patients. It is concluded that clinical examination, supplied with T4, T3, T3-test, and TSH determinations 12–14 weeks after therapy seems rational as a first step in the lifelong follow-up of these patients.

This is a preview of subscription content, log in to check access.


T4 :


T3 :



triiodothyronine uptake test


thyroid stimulating hormone


free thyroxin index


  1. Auto-Analyzer Method File N52. Technicon Instruments Corporation, Tarrytown, New York, USA

  2. Beierwaltes, W.H.: The treatment of hyperthyroidism with iodine-131. Semin. Nucl. Med. 8, 95–103 (1978)

  3. Bellabarba, D., Bénard, B., Langlois, M.: Pattern of serum thyroxine, triiodothyronine and thyrotropin after treatment of thyrotoxicosis. Clin. Endocrinol. 1, 345–353 (1972)

  4. Chapman, E.M.: Treatment of hyperthyroidism with radioactive iodine. In: Nuclear medicine, W.H. Bladh (ed.), pp. 711–734. New York: McGraw Hill Book Company 1971

  5. Greig, W.R.: Radioactive iodine therapy for thyrotoxicosis. Br. J. Surg. 60, 758–765 (1973)

  6. Groot, L. de, Stanbury, J. B.: The thyroid and its diseases, 4th ed., pp. 314–367. New York-London-Sidney-Toronto: John Wiley & Sons 1975

  7. Hamilton, J.G., Lawrence, J.H.: Recent clinical developments in the therapeutic application of radio-phosphorus and radio-iodine. J. Clin. Invest. 21, 624 (1942)

  8. Hayek, A.: Thyroid storm following radioiodine for thyrotoxicosis. J. Pediatr. 93, 978–980 (1978)

  9. Hertz, S., Roberts, A.: Application of radioactive iodine in therapy for Graves' disease. J. Clin. Invest. 21, 624 (1942)

  10. Lamberg, B.-A.: Sköldkörtels sjukdomar, pp. 219–237. Helsingfors: Remedia Fennica 1969

  11. Maxon, H.R., Thomas, S.R., Saenger, E.L., Buncher, C.R., Kereiakes, J.G.: Ionizing irridation and the induction of clinically significant disease in the human thyroid gland. Am. J. Med. 63, 967–978 (1977)

  12. Rootwelt, K., Solberg, H.E.: Optimum laboratory rest combinations for thyroid function studies, selected by discriminant analysis. Scand. J. Clin. Lab. Invest. 38, 477–485 (1978)

  13. Shafer, R.B., Nuttall, F.Q.: Acute changes in thyroid function in patients treated with radioactive iodine. Lancet 2, 635–637 (1975)

  14. Technicon Work-sheet AA II-24th May 1971. Technicon Instruments Corporation, Tarrytown, New York, USA

  15. Toft, A.D., Irvine, W.J., Hunter, W.M., Ratclife, J.G., Seth, J.: TSH and thyroid hormone levels after 131I therapy for thyrotoxicosis. In: Thyroid hormone metabolism, W.A.Harland and J.S.Orr (eds.), pp. 383–393. London-New York-San Francisco: Academic Press 1975

  16. Toft, A.D., Irvine, W.J., Seth, J., Cameron, E.H.D.: How often should patients be reviewed after treatment with iodine-131 for thyrotoxicosis? Br. Med. J. 2, 1115–1117 (1978)

  17. Tunbridge, W.M.G., Harsoulis, P., Goolden, A.W.G.: Thyroid function in patients treated with radioactive iodine for thyrotoxicosis. Br. Med. J. 3, 89–92 (1974)

  18. Wenzel, K.W., Meinhold, H., Raffenberg, M., Adlkofer, F., Schleusener, H.: Classification of hypothyroidism in evaluating patients after radioiodine therapy by serum cholesterol, T3-uptake total T4, FT4-index, total T3, basal TSH and TRH-test. Eur. J. Clin. Invest. 4, 141–148 (1974)

Download references

Author information

Correspondence to L. N. W. Daae.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Daae, L.N.W., Solheim, D.M. The early follow-up of 131I-treatment of thyrotoxicosis. Eur J Nucl Med 5, 199–203 (1980). https://doi.org/10.1007/BF00271899

Download citation


  • Public Health
  • Nuclear Medicine
  • Clinical Examination
  • Control Parameter
  • Thyrotoxicosis